+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Intranasal Drug Delivery - Global Market Trajectory & Analytics

  • ID: 516888
  • Report
  • September 2020
  • Region: Global
  • 307 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • AptarGroup, Inc. (USA)
  • AstraZeneca Plc. (UK)
  • GlaxoSmithKline Plc. (UK)
  • MedImmune, Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Nemera (France)
  • MORE
Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Spray, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$19.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drop segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U. S. Market is Estimated at $12.1 Billion, While China is Forecast to Grow at 6.3% CAGR

The Intranasal Drug Delivery market in the U. S. is estimated at US$12.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.8 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Gel Segment to Record 3.6% CAGR

In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$8 Billion in the year 2020 will reach a projected size of US$10 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.8 Billion by the year 2027, while Latin America will expand at a 4.5% CAGR through the analysis period. We bring years of research experience to this 15th edition of our report. The 307-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Aegis Therapeutics LLC
  • AptarGroup, Inc.
  • AstraZeneca Plc
  • Becton Dickinson and Company
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Marina Biotech, Inc.
  • MedImmune, Inc.
  • Merck & Co., Inc.
  • Nemera
  • Novartis AG
  • OptiNose US Inc.
  • Pfizer Inc.
  • Valeant Pharmaceuticals International, Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AptarGroup, Inc. (USA)
  • AstraZeneca Plc. (UK)
  • GlaxoSmithKline Plc. (UK)
  • MedImmune, Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Nemera (France)
  • MORE
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • A Prelude
  • Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier
  • Recent Market Activity
  • Factors Inhibiting Nose-to-Brain Transportation of Drugs
  • Bioavailability: An Important Facet of Intranasal Drug Delivery
  • Outlook
  • Nasal Drug Delivery Devices & Equipment
  • Traditional Vs. Advanced Intranasal Drug Formulation Types
  • Global Competitor Market Shares
  • Intranasal Drug Delivery Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies
  • Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
  • Pharmaceutical and Medical Device Companies Vying to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients
  • The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
  • The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
  • The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
  • The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
  • Intranasal Corticosteroids - A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease
  • Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight
  • Innovation in Drug Delivery: A Talisman for Success
  • Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications
  • Controlled Release Technology Is the Buzz Word
  • Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery
  • Tight Junction Biology: A Key Speed Breaker in Commercialization
  • RNA Interference (RNAi): A Tool to Manipulate Tight Junctions
  • Research Studies Authenticate Benefits of Bi-Directional Nasal Drug Delivery
  • Growing Interest for Preservative-free Nasal Spray Formulations
  • Multi-Dose Containers Developed to Offer Resistance against Microbial Contamination
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Intranasal Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Intranasal Drug Delivery Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Intranasal Drug Delivery Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Spray (Dosage Form) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Spray (Dosage Form) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Spray (Dosage Form) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Drop (Dosage Form) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Drop (Dosage Form) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Drop (Dosage Form) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Gel (Dosage Form) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Gel (Dosage Form) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Gel (Dosage Form) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Powder (Dosage Form) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Powder (Dosage Form) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Powder (Dosage Form) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Nasal Congestion (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 17: Nasal Congestion (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 18: Nasal Congestion (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Rhinitis (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 20: Rhinitis (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 21: Rhinitis (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Asthma (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Asthma (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Asthma (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 26: Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 27: Other Applications (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Intranasal Drug Delivery Market Share (in %) by Company: 2018 & 2025
  • Market Analytics
  • TABLE 28: United States Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 29: Intranasal Drug Delivery Market in the United States by Dosage Form: A Historic Review in US$ Million for 2012-2019
  • TABLE 30: United States Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 31: United States Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 32: Intranasal Drug Delivery Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
  • TABLE 33: Intranasal Drug Delivery Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
CANADA
  • TABLE 34: Canadian Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 35: Canadian Intranasal Drug Delivery Historic Market Review by Dosage Form in US$ Million: 2012-2019
  • TABLE 36: Intranasal Drug Delivery Market in Canada: Percentage Share Breakdown of Sales by Dosage Form for 2012, 2020, and 2027
  • TABLE 37: Canadian Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 38: Intranasal Drug Delivery Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 39: Canadian Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
JAPAN
  • TABLE 40: Japanese Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 41: Intranasal Drug Delivery Market in Japan: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019
  • TABLE 42: Japanese Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 43: Japanese Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 44: Japanese Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019
  • TABLE 45: Intranasal Drug Delivery Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
CHINA
  • TABLE 46: Chinese Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 47: Intranasal Drug Delivery Historic Market Analysis in China in US$ Million by Dosage Form: 2012-2019
  • TABLE 48: Chinese Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 49: Chinese Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 50: Intranasal Drug Delivery Market Review in China in US$ Million by Application: 2012-2019
  • TABLE 51: Chinese Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European Intranasal Drug Delivery Market: Competitor Market Share Scenario (in %) for 2018 & 2025
  • Market Analytics
  • TABLE 52: European Intranasal Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 53: Intranasal Drug Delivery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 54: European Intranasal Drug Delivery Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 55: European Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027
  • TABLE 56: Intranasal Drug Delivery Market in Europe in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019
  • TABLE 57: European Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 58: European Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 59: Intranasal Drug Delivery Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 60: European Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 61: Intranasal Drug Delivery Market in France by Dosage Form: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 62: French Intranasal Drug Delivery Historic Market Scenario in US$ Million by Dosage Form: 2012-2019
  • TABLE 63: French Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 64: Intranasal Drug Delivery Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
  • TABLE 65: French Intranasal Drug Delivery Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 66: French Intranasal Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
  • TABLE 67: Intranasal Drug Delivery Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 68: German Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019
  • TABLE 69: German Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 70: Intranasal Drug Delivery Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 71: German Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 72: Intranasal Drug Delivery Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
ITALY
  • TABLE 73: Italian Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 74: Intranasal Drug Delivery Historic Market Analysis in Italy in US$ Million by Dosage Form: 2012-2019
  • TABLE 75: Italian Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 76: Italian Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 77: Intranasal Drug Delivery Market Review in Italy in US$ Million by Application: 2012-2019
  • TABLE 78: Italian Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
  • TABLE 79: United Kingdom Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 80: Intranasal Drug Delivery Market in the United Kingdom: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019
  • TABLE 81: United Kingdom Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 82: United Kingdom Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 83: United Kingdom Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019
  • TABLE 84: Intranasal Drug Delivery Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
SPAIN
  • TABLE 85: Spanish Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 86: Spanish Intranasal Drug Delivery Historic Market Review by Dosage Form in US$ Million: 2012-2019
  • TABLE 87: Intranasal Drug Delivery Market in Spain: Percentage Share Breakdown of Sales by Dosage Form for 2012, 2020, and 2027
  • TABLE 88: Spanish Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 89: Intranasal Drug Delivery Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 90: Spanish Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
RUSSIA
  • TABLE 91: Russian Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 92: Intranasal Drug Delivery Market in Russia by Dosage Form: A Historic Review in US$ Million for 2012-2019
  • TABLE 93: Russian Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 94: Russian Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 95: Intranasal Drug Delivery Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019
  • TABLE 96: Intranasal Drug Delivery Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 97: Rest of Europe Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027
  • TABLE 98: Intranasal Drug Delivery Market in Rest of Europe in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019
  • TABLE 99: Rest of Europe Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 100: Rest of Europe Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 101: Intranasal Drug Delivery Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 102: Rest of Europe Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 103: Asia-Pacific Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 104: Intranasal Drug Delivery Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 105: Asia-Pacific Intranasal Drug Delivery Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 106: Intranasal Drug Delivery Market in Asia-Pacific by Dosage Form: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 107: Asia-Pacific Intranasal Drug Delivery Historic Market Scenario in US$ Million by Dosage Form: 2012-2019
  • TABLE 108: Asia-Pacific Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 109: Intranasal Drug Delivery Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
  • TABLE 110: Asia-Pacific Intranasal Drug Delivery Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 111: Asia-Pacific Intranasal Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
AUSTRALIA
  • TABLE 112: Intranasal Drug Delivery Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 113: Australian Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019
  • TABLE 114: Australian Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 115: Intranasal Drug Delivery Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 116: Australian Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 117: Intranasal Drug Delivery Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027
INDIA
  • TABLE 118: Indian Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 119: Indian Intranasal Drug Delivery Historic Market Review by Dosage Form in US$ Million: 2012-2019
  • TABLE 120: Intranasal Drug Delivery Market in India: Percentage Share Breakdown of Sales by Dosage Form for 2012, 2020, and 2027
  • TABLE 121: Indian Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 122: Intranasal Drug Delivery Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 123: Indian Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
SOUTH KOREA
  • TABLE 124: Intranasal Drug Delivery Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 125: South Korean Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019
  • TABLE 126: Intranasal Drug Delivery Market Share Distribution in South Korea by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 127: Intranasal Drug Delivery Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
  • TABLE 128: South Korean Intranasal Drug Delivery Historic Market Analysis in US$ Million by Application: 2012-2019
  • TABLE 129: Intranasal Drug Delivery Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
  • TABLE 130: Rest of Asia-Pacific Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 131: Intranasal Drug Delivery Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019
  • TABLE 132: Rest of Asia-Pacific Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 133: Rest of Asia-Pacific Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 134: Rest of Asia-Pacific Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019
  • TABLE 135: Intranasal Drug Delivery Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027
LATIN AMERICA
  • TABLE 136: Latin American Intranasal Drug Delivery Market Trends by Region/Country in US$ Million: 2020-2027
  • TABLE 137: Intranasal Drug Delivery Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
  • TABLE 138: Latin American Intranasal Drug Delivery Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
  • TABLE 139: Latin American Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 140: Intranasal Drug Delivery Historic Market Analysis in Latin America in US$ Million by Dosage Form: 2012-2019
  • TABLE 141: Latin American Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 142: Latin American Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 143: Intranasal Drug Delivery Market Review in Latin America in US$ Million by Application: 2012-2019
  • TABLE 144: Latin American Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027
ARGENTINA
  • TABLE 145: Argentinean Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027
  • TABLE 146: Intranasal Drug Delivery Market in Argentina in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019
  • TABLE 147: Argentinean Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 148: Argentinean Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 149: Intranasal Drug Delivery Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 150: Argentinean Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
BRAZIL
  • TABLE 151: Intranasal Drug Delivery Market in Brazil by Dosage Form: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 152: Brazilian Intranasal Drug Delivery Historic Market Scenario in US$ Million by Dosage Form: 2012-2019
  • TABLE 153: Brazilian Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 154: Intranasal Drug Delivery Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027
  • TABLE 155: Brazilian Intranasal Drug Delivery Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 156: Brazilian Intranasal Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
MEXICO
  • TABLE 157: Intranasal Drug Delivery Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 158: Mexican Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019
  • TABLE 159: Mexican Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 160: Intranasal Drug Delivery Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 161: Mexican Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 162: Intranasal Drug Delivery Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
  • TABLE 163: Rest of Latin America Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 164: Intranasal Drug Delivery Market in Rest of Latin America by Dosage Form: A Historic Review in US$ Million for 2012-2019
  • TABLE 165: Rest of Latin America Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 166: Rest of Latin America Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 167: Intranasal Drug Delivery Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019
  • TABLE 168: Intranasal Drug Delivery Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027
MIDDLE EAST
  • TABLE 169: The Middle East Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 170: Intranasal Drug Delivery Market in the Middle East by Region/Country in US$ Million: 2012-2019
  • TABLE 171: The Middle East Intranasal Drug Delivery Market Share Breakdown by Region/Country: 2012, 2020, and 2027
  • TABLE 172: The Middle East Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 173: The Middle East Intranasal Drug Delivery Historic Market by Dosage Form in US$ Million: 2012-2019
  • TABLE 174: Intranasal Drug Delivery Market in the Middle East: Percentage Share Breakdown of Sales by Dosage Form for 2012,2020, and 2027
  • TABLE 175: The Middle East Intranasal Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 176: Intranasal Drug Delivery Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 177: The Middle East Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
IRAN
  • TABLE 178: Iranian Market for Intranasal Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 179: Intranasal Drug Delivery Market in Iran: Historic Sales Analysis in US$ Million by Dosage Form for the Period 2012-2019
  • TABLE 180: Iranian Intranasal Drug Delivery Market Share Analysis by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 181: Iranian Demand Estimates and Forecasts for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 182: Iranian Intranasal Drug Delivery Market in US$ Million by Application: 2012-2019
  • TABLE 183: Intranasal Drug Delivery Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027
ISRAEL
  • TABLE 184: Israeli Intranasal Drug Delivery Market Estimates and Forecasts in US$ Million by Dosage Form: 2020-2027
  • TABLE 185: Intranasal Drug Delivery Market in Israel in US$ Million by Dosage Form: A Historic Review for the Period 2012-2019
  • TABLE 186: Israeli Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 187: Israeli Intranasal Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 188: Intranasal Drug Delivery Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 189: Israeli Intranasal Drug Delivery Market Share Analysis by Application: 2012 VS 2020 VS 2027
SAUDI ARABIA
  • TABLE 190: Saudi Arabian Intranasal Drug Delivery Market Growth Prospects in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 191: Intranasal Drug Delivery Historic Market Analysis in Saudi Arabia in US$ Million by Dosage Form: 2012-2019
  • TABLE 192: Saudi Arabian Intranasal Drug Delivery Market by Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 193: Saudi Arabian Demand for Intranasal Drug Delivery in US$ Million by Application: 2020 to 2027
  • TABLE 194: Intranasal Drug Delivery Market Review in Saudi Arabia in US$ Million by Application: 2012-2019
  • TABLE 195: Saudi Arabian Intranasal Drug Delivery Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
  • TABLE 196: Intranasal Drug Delivery Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 197: United Arab Emirates Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019
  • TABLE 198: Intranasal Drug Delivery Market Share Distribution in United Arab Emirates by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 199: Intranasal Drug Delivery Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
  • TABLE 200: United Arab Emirates Intranasal Drug Delivery Historic Market Analysis in US$ Million by Application: 2012-2019
  • TABLE 201: Intranasal Drug Delivery Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
  • TABLE 202: Intranasal Drug Delivery Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Dosage Form for the Period 2020-2027
  • TABLE 203: Rest of Middle East Intranasal Drug Delivery Historic Market Analysis in US$ Million by Dosage Form: 2012-2019
  • TABLE 204: Rest of Middle East Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 205: Intranasal Drug Delivery Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 206: Rest of Middle East Intranasal Drug Delivery Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 207: Intranasal Drug Delivery Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027
AFRICA
  • TABLE 208: African Intranasal Drug Delivery Market Estimates and Projections in US$ Million by Dosage Form: 2020 to 2027
  • TABLE 209: Intranasal Drug Delivery Market in Africa by Dosage Form: A Historic Review in US$ Million for 2012-2019
  • TABLE 210: African Intranasal Drug Delivery Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027
  • TABLE 211: African Intranasal Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 212: Intranasal Drug Delivery Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019
  • TABLE 213: Intranasal Drug Delivery Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 64
Note: Product cover images may vary from those shown
  • Aegis Therapeutics LLC (USA)
  • AptarGroup, Inc. (USA)
  • AstraZeneca Plc. (UK)
  • MedImmune, Inc. (USA)
  • Becton Dickinson and Company (USA)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson Inc. (USA)
  • Marina Biotech, Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Nemera (France)
  • Novartis AG (Switzerland)
  • OptiNose US Inc. (USA)
  • Pfizer, Inc. (USA)
  • Valeant Pharmaceuticals International, Inc. (Canada)
Note: Product cover images may vary from those shown
Adroll
adroll